カテゴリ： MarketLine, イギリス, 企業調査

HSBC Holdings Plc：企業の戦略・SWOT・財務情報

◆英語タイトル：HSBC Holdings Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15387
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：65
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

HSBC Holdings Plc – Strategy, SWOT and Corporate Finance Report
Summary

HSBC Holdings Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

HSBC Holdings Plc (HSBC) is a provider of banking and financial solutions. It offers retail, business, and commercial banking; private banking; and wealth management services through its subsidiaries. The group’s offerings include personal and commercial loans, deposit services, mortgages, card products, insurance solutions, asset management, working capital and term loans, payment services, international trade facilitation, merger and acquisition advisory, transaction banking, capital markets and risk management, investment management, and trusts and estate planning. The group has a presence in Europe, Asia, MENA, North America, and Latin America. HSBC is headquartered in London, the UK.

Scope

- Detailed information on HSBC Holdings Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting HSBC Holdings Plc in the form of a SWOT analysis
- An in-depth view of the business model of HSBC Holdings Plc including a breakdown and examination of key business segments
- Intelligence on HSBC Holdings Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about HSBC Holdings Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of HSBC Holdings Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess HSBC Holdings Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on HSBC Holdings Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
HSBC Holdings Plc: Company Overview
HSBC Holdings Plc: Overview and Key Facts
HSBC Holdings Plc: Overview
HSBC Holdings Plc: Key Facts
HSBC Holdings Plc: Key Employees
HSBC Holdings Plc: Key Employee Biographies
HSBC Holdings Plc: Major Products and Services
HSBC Holdings Plc: Company History
HSBC Holdings Plc: Management Statement
HSBC Holdings Plc: Locations and Subsidiaries
HSBC Holdings Plc: Key Competitors
HSBC Holdings Plc: Company Analysis
HSBC Holdings Plc: Business Description
HSBC Holdings Plc: SWOT Analysis
HSBC Holdings Plc: SWOT Overview
HSBC Holdings Plc: Strengths
HSBC Holdings Plc: Weaknesses
HSBC Holdings Plc: Opportunities
HSBC Holdings Plc: Threats
HSBC Holdings Plc: Corporate Financial Deals Activity
HSBC Holdings Plc: Financial Deals Overview
HSBC Holdings Plc: Targets and Partners
HSBC Holdings Plc: Top Deals 2015 – 2019YTD*
HSBC Holdings Plc: Advisors
HSBC Holdings Plc: Top Legal Advisors
HSBC Holdings Plc: Top Financial Advisors
HSBC Holdings Plc: Mergers and Acquisitions
HSBC Holdings Plc: Corporate Venturing
HSBC Holdings Plc: Capital Raising
HSBC Holdings Plc: Partnership
HSBC Holdings Plc: Divestments
HSBC Holdings Plc: Recent Developments
HSBC Holdings Plc: News and Events Summary
HSBC Holdings Plc: Business Reorganization
HSBC Holdings Plc: Contracts
HSBC Holdings Plc: Corporate Governance
HSBC Holdings Plc: IT Spending Announcements
HSBC Holdings Plc: Regulatory and Legal Events
HSBC Holdings Plc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: HSBC Holdings Plc: Key Facts
Table 2: HSBC Holdings Plc: Key Employees
Table 3: HSBC Holdings Plc: Company History
Table 4: HSBC Holdings Plc: Locations and Subsidiaries
Table 5: HSBC Holdings Plc: Key Competitors
Table 6: HSBC Holdings Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: HSBC Holdings Plc: M&A Activity by Geography (TTM*)
Table 8: HSBC Holdings Plc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: HSBC Holdings Plc: M&A Average Deal Size - Value (US$m)
Table 10: HSBC Holdings Plc: Targets and Partners
Table 11: HSBC Holdings Plc: Top Deals 2015 - 2019YTD*
Table 12: HSBC Holdings Plc: Legal Advisor Ranking by Value (US$m)
Table 13: HSBC Holdings Plc: Financial Advisor Ranking by Value (US$m)
Table 14: HSBC Holdings Plc: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: HSBC Holdings Plc: M&A Activity by Geography (2015 - YTD*2019)
Table 16: HSBC Holdings Plc: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 17: HSBC Holdings Plc: Corporate Venturing by Geography (2015 - YTD*2019)
Table 18: HSBC Holdings Plc: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 19: HSBC Holdings Plc: Capital Raising by Deal Type (2015 - YTD*2019)
Table 20: HSBC Holdings Plc: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 21: HSBC Holdings Plc: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 22: HSBC Holdings Plc: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 23: HSBC Holdings Plc: Divestments by Geography (2015 - YTD*2019)
Table 24: HSBC Holdings Plc: News and Events Summary
Table 25: HSBC Holdings Plc: Business Reorganization
Table 26: HSBC Holdings Plc: Contracts
Table 27: HSBC Holdings Plc: Corporate Governance
Table 28: HSBC Holdings Plc: IT Spending Announcements
Table 29: HSBC Holdings Plc: Regulatory and Legal Events
Table 30: HSBC Holdings Plc: Strategy and Operations

List of Figures
Figure 1: HSBC Holdings Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: HSBC Holdings Plc: M&A Activity by Geography (TTM*)
Figure 3: HSBC Holdings Plc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: HSBC Holdings Plc: M&A Average Deal Size - Value (US$m)
Figure 5: HSBC Holdings Plc: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: HSBC Holdings Plc: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: HSBC Holdings Plc: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 8: HSBC Holdings Plc: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 9: HSBC Holdings Plc: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 10: HSBC Holdings Plc: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 11: HSBC Holdings Plc: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 12: HSBC Holdings Plc: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 13: HSBC Holdings Plc: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 14: HSBC Holdings Plc: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[HSBC Holdings Plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Titan Pharmaceuticals Inc (TTNP)：企業の財務・戦略的SWOT分析
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • Alligator Bioscience AB (ATORX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Alligator Bioscience AB (Alligator Bioscience) is a clinical-stage biotechnology company that discovers and develops antibody based pharmaceuticals for the treatment of cancer. The company’s pipeline products include ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527. The ADC-1013, currently und …
  • DiaMedica Therapeutics Inc (DMA)：医療機器：M&Aディール及び事業提携情報
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • Metropolitan Bank & Trust Company (MBT)：企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • The E. W. Scripps Company：戦略・SWOT・企業財務分析
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SurgaColl Technologies Ltd：製品パイプライン分析
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops regenerative technologies. The company’s products comprise hydroxycoll and chondrocoll. It offers regenerative solutions in the field of bone, cartilage and osteochondral tissue regeneration. SurgaC …
  • New York Power Authority：企業の戦略・SWOT・財務分析
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Juwi Inc：電力：M&Aディール及び事業提携情報
    Summary Juwi Inc (Juwi), a subsidiary of juwi AG is a renewable energy company that operates wind and solar projects. The company’s services include development and acquisition, engineering, procurement, construction and operations and maintenance. Juwi's operations and maintenance services comprise …
  • Dubai Electricity and Water Authority：企業の戦略的SWOT分析
    Dubai Electricity and Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Alibaba Group Holding Limited：企業のM&A・事業提携・投資動向
    Alibaba Group Holding Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alibaba Group Holding Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • YTL Power International Berhad：発電所・企業SWOT分析
    YTL Power International Berhad – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Nexstim Plc (NXTMH)-医療機器分野：企業M&A・提携分析
    Summary Nexstim Plc (Nexstim) is a medical technology company, which focuses on navigated brain stimulation (NBS) to improve rehabilitation in stroke patients non-invasively . Its NBS system, which is FDA cleared and CE-marked, applies navigated transcranial magnetic stimulation (nTMS) device for pr …
  • ProteinSimple-製薬・医療分野：企業M&A・提携分析
    Summary ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation s …
  • SpringWorks Therapeutics LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary SpringWorks Therapeutics LLC (SpringWorks Therapeutics) is a drug development company that develops therapeutic medicines for various diseases. The company’s pipeline products include Nirogacestat, MEK ½ Inhibitor, Senicapoc and FAAH Inhibitor. Its Nirogacestat is a gamma secretase inhibitor …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野：企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Harrison Catering Services Ltd.：企業の戦略・SWOT・財務情報
    Harrison Catering Services Ltd. - Strategy, SWOT and Corporate Finance Report Summary Harrison Catering Services Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sanford Burnham Prebys Medical Discovery Institute：製薬・医療：M&Aディール及び事業提携情報
    Summary Sanford Burnham Prebys Medical Discovery Institute (SBP) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microenvironment a …
  • Spherix Inc (SPEX)：企業の財務・戦略的SWOT分析
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • GeNeuro SA (GNRO)：企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • KT&G Corp：企業の戦略・SWOT・財務情報
    KT&G Corp - Strategy, SWOT and Corporate Finance Report Summary KT&G Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆